Articles with "site inhibitors" as a keyword



Photo by homajob from unsplash

High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.

Sign Up to like & get
recommendations!
Published in 2020 at "Biochemical and biophysical research communications"

DOI: 10.1016/j.bbrc.2020.11.082

Abstract: Microtubule is a key component of cytoskeleton and has been considered as an important target for the treatment of cancer. In particular, the tubulin taxane-site inhibitors such as taxol analogs and epothilones have achieved great… read more here.

Keywords: microtubule; site inhibitors; site; taxane site ... See more keywords
Photo by homajob from unsplash

1-Phenyl-dihydrobenzoindazoles as novel colchicine site inhibitors: Structural basis and antitumor efficacy.

Sign Up to like & get
recommendations!
Published in 2019 at "European journal of medicinal chemistry"

DOI: 10.1016/j.ejmech.2019.04.040

Abstract: The colchicine site inhibitors (CSIs) showed promising prospects as antitumor agents due to their vascular disrupting activities besides antimitotic activities. 1-Phenyl-dihydrobenzoindazole was found as a novel scaffold of CSI without the cis-trans isomerization problem. The… read more here.

Keywords: phenyl dihydrobenzoindazoles; site inhibitors; antitumor; colchicine site ... See more keywords
Photo by homajob from unsplash

Design, Synthesis, and Proof-of-Concept of Triple-Site Inhibitors against Aminoacyl-tRNA Synthetases.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.2c00134

Abstract: Aminoacyl-tRNA synthetases (aaRSs) are promising drug targets due to their essential roles in protein translation. Although current inhibitors primarily occupy one or two of the three substrate binding sites on aaRSs, we report here the… read more here.

Keywords: aminoacyl trna; triple site; proof concept; site ... See more keywords
Photo by homajob from unsplash

WIN site inhibition disrupts a subset of WDR5 function

Sign Up to like & get
recommendations!
Published in 2022 at "Scientific Reports"

DOI: 10.1038/s41598-022-05947-9

Abstract: WDR5 nucleates the assembly of histone-modifying complexes and acts outside this context in a range of chromatin-centric processes. WDR5 is also a prominent target for pharmacological inhibition in cancer. Small-molecule degraders of WDR5 have been… read more here.

Keywords: site inhibition; subset wdr5; win site; site ... See more keywords
Photo from wikipedia

Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Enzyme Inhibition and Medicinal Chemistry"

DOI: 10.1080/14756366.2021.1883598

Abstract: Abstract Discovering of new anticancer agents with potential activity against tubulin polymerisation is still a promising approach. Colchicine binding site inhibitors are the most relevant anti-tubulin polymerisation agents. Thus, new quinoline derivatives have been designed… read more here.

Keywords: site inhibitors; binding site; tubulin polymerisation; colchicine binding ... See more keywords